Small Molecule Therapeutics for Schizophrenia
(Sprache: Englisch)
The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design...
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
Fr. 130.90
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Small Molecule Therapeutics for Schizophrenia “
Klappentext zu „Small Molecule Therapeutics for Schizophrenia “
The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine.
Inhaltsverzeichnis zu „Small Molecule Therapeutics for Schizophrenia “
Antipsychotics and the Dopamine-Serotonin Connection.- GLYT1 Inhibitors: From Hits to Clinical Candidates.- Metabotropic Glutamate Receptor 2 Activators.- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders.- Muscarinic Acetylcholine Receptor Activators.- Nicotinic Acetylcholine Receptor Modulators.-The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.
Bibliographische Angaben
- 2016, Softcover reprint of the original 1st ed. 2015, VII, 323 Seiten, 23 farbige Abbildungen, Masse: 15,5 x 23,5 cm, Kartoniert (TB), Englisch
- Herausgegeben: Sylvain Celanire, Sonia Poli
- Verlag: Springer, Berlin
- ISBN-10: 3319378945
- ISBN-13: 9783319378947
Sprache:
Englisch
Pressezitat
From the book reviews:"The target audience ... is primarily researchers in psychopharmacology involved in drug development. ... Each chapter concludes with citations of the pertinent scientific literature. This book covering small molecular therapeutics for schizophrenia would be a useful review for researchers studying this area." (Michael Joel Schrift, Doody's Book Reviews, March, 2015)
Kommentar zu "Small Molecule Therapeutics for Schizophrenia"
0 Gebrauchte Artikel zu „Small Molecule Therapeutics for Schizophrenia“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Small Molecule Therapeutics for Schizophrenia".
Kommentar verfassen